Ailomics Therapeutics
Latest round
- Angel
Last raised
- Sep 2022
Total raised
- Undisclosed
Investors
- 3
About Ailomics Therapeutics
Based in Shanghai, China, and founded in 2022, Ailomics Therapeutics operates as a developer of innovative drugs. It has established a new drug development center in Shanghai. The founder and CEO, Dr. Qing Zhang spent 14 years at GSK, Amgen, and Roche, where he worked on small molecule and antibody drug design, target discovery, and validation. The co-founder Dr. Ting Ban worked at Roche and Amgen. Through deep learning and other AI technologies, the company analyzes multi-omics big data (including single cell and spatial histology) from patients to discover key cell types and intra- and extracellular signaling pathways that lead to disease progression, and select new targets that have the potential to address clinical needs for the development of First-in-class drugs.
Who invested in Ailomics Therapeutics
3 investors across 1 round
See all investors in Ailomics Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 19, 2022
Amount
Undisclosed
Investors
Questions about Ailomics Therapeutics
Who invested in Ailomics Therapeutics?
Ailomics Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ailomics Therapeutics raised?
Ailomics Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ailomics Therapeutics last raise money?
Ailomics Therapeutics's most recent round on record is a Angel, in Sep 2022.
What does Ailomics Therapeutics do?
Based in Shanghai, China, and founded in 2022, Ailomics Therapeutics operates as a developer of innovative drugs.
Where is Ailomics Therapeutics headquartered?
Ailomics Therapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Ailomics Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Ailomics Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Ailomics Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.